These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6327962)

  • 61. [Dynamics of secretion of hypothalamo-hypophyseal system hormones in Itsenko-Cushing disease as affected by combination therapy].
    Slavnov VN; Valueva GV; Luchitskiĭ EV; Komissarenko IV; Cheban AK
    Probl Endokrinol (Mosk); 1983; 29(6):28-32. PubMed ID: 6140677
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.
    Atkinson AB; Kennedy AL; Sheridan B
    Postgrad Med J; 1985 Mar; 61(713):239-42. PubMed ID: 2984649
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Prolonged remission in Cushing's syndrome following treatment with ortho-para-dichlordiphenyldichlorethane].
    Kirkegaard C; Kolendorf K
    Ugeskr Laeger; 1974 Jun; 136(25):1389-91. PubMed ID: 4366485
    [No Abstract]   [Full Text] [Related]  

  • 64. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease.
    Lankford HV; Tucker HS; Blackard WG
    N Engl J Med; 1981 Nov; 305(21):1244-8. PubMed ID: 6270557
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Medical treatment and Cushing's disease].
    Luton JP; Ghnassia JP; Bricaire H
    Sem Hop; 1977 Jun; 53(24):1476-9. PubMed ID: 197640
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Non-invasive therapy of Cushing's syndrome].
    Miura K
    Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1627-32. PubMed ID: 7798761
    [No Abstract]   [Full Text] [Related]  

  • 67. [Therapy of Cushing's syndrome].
    Labhart A
    Dtsch Med Wochenschr; 1969 Jan; 94(1):36-7. PubMed ID: 4302213
    [No Abstract]   [Full Text] [Related]  

  • 68. Cortisol and androgen secretion in a case of Nelson's syndrome with paratesticular tumors: response to cyproheptadine therapy.
    Krieger DT; Samojlik E; Bardin CW
    J Clin Endocrinol Metab; 1978 Oct; 47(4):837-44. PubMed ID: 233683
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing's syndrome: evidence for more than one abnormal ACTH biorhythm.
    Jordan RM; Ramos-Gabatin A; Kendall JW; Gaudette D; Walls RC
    J Clin Endocrinol Metab; 1982 Sep; 55(3):531-7. PubMed ID: 6284783
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cushing's syndrome.
    McPherson HT
    Urol Clin North Am; 1977 Jun; 4(2):211-26. PubMed ID: 197679
    [No Abstract]   [Full Text] [Related]  

  • 71. ACTH independent Cushing's disease.
    Lindholm J; Christensen L; Therkildsen MH
    J Endocrinol Invest; 1990 May; 13(5):433-4. PubMed ID: 2166104
    [No Abstract]   [Full Text] [Related]  

  • 72. Ketoconazole treatment for Cushing syndrome in McCune-Albright syndrome.
    Vong CH; Forest M; Nicolino M
    J Pediatr; 2009 Mar; 154(3):467-8; author reply 468-9. PubMed ID: 19874777
    [No Abstract]   [Full Text] [Related]  

  • 73. [Clinical remission in Cushing's disease through treatment with sodium valproate and bromocriptine].
    García Rojas JF; Mangas Rojas A; Barba Chacón A; García Osle M; Zamora Madaria E
    Rev Clin Esp; 1991 Jan; 188(1):37-40. PubMed ID: 2063025
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Recovery or remission of Cushing's disease following long term administration of OP'DDD in seventeen patients (author's transl)].
    Luton JP; Remy JM; Valcke JC; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1973; 34(4):351-76. PubMed ID: 4360563
    [No Abstract]   [Full Text] [Related]  

  • 75. Cyproheptadine inhibits the corticotropin releasing hormone (CRH)--induced hormone release in normal subjects.
    Allolio B; Schulte HM; Deuss U; Winkelmann W
    Horm Metab Res Suppl; 1987; 16():36-8. PubMed ID: 2832287
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The biochemical investigation of Cushing syndrome.
    Simard M
    Neurosurg Focus; 2004 Apr; 16(4):E4. PubMed ID: 15191333
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Pharmacologic treatment of Cushing's syndrome].
    Díez JJ
    Med Clin (Barc); 1998 Jun; 110(20):781-96. PubMed ID: 9666420
    [No Abstract]   [Full Text] [Related]  

  • 78. [Drug therapy of pituitary tumors].
    Kato Y
    Nihon Naika Gakkai Zasshi; 1991 Mar; 80(3):368-72. PubMed ID: 1856549
    [No Abstract]   [Full Text] [Related]  

  • 79. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
    Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M; Laudat MH; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.